[go: up one dir, main page]

AU2003249904A1 - Stable oily suspension of microgranules - Google Patents

Stable oily suspension of microgranules

Info

Publication number
AU2003249904A1
AU2003249904A1 AU2003249904A AU2003249904A AU2003249904A1 AU 2003249904 A1 AU2003249904 A1 AU 2003249904A1 AU 2003249904 A AU2003249904 A AU 2003249904A AU 2003249904 A AU2003249904 A AU 2003249904A AU 2003249904 A1 AU2003249904 A1 AU 2003249904A1
Authority
AU
Australia
Prior art keywords
microgranules
oily suspension
stable oily
stable
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003249904A
Other versions
AU2003249904A8 (en
Inventor
Beatriz Artalejo Ortega
Javier Batllori Calbo
Andres Fernandez Garcia
Jordi Julve Rubio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat SA filed Critical Laboratorios Salvat SA
Publication of AU2003249904A8 publication Critical patent/AU2003249904A8/en
Publication of AU2003249904A1 publication Critical patent/AU2003249904A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003249904A 2002-07-02 2003-06-30 Stable oily suspension of microgranules Abandoned AU2003249904A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200201610 2002-07-02
ES200201610 2002-07-02
PCT/EP2003/006927 WO2004004682A2 (en) 2002-07-02 2003-06-30 Stable oily suspension of microgranules

Publications (2)

Publication Number Publication Date
AU2003249904A8 AU2003249904A8 (en) 2004-01-23
AU2003249904A1 true AU2003249904A1 (en) 2004-01-23

Family

ID=30011360

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003249904A Abandoned AU2003249904A1 (en) 2002-07-02 2003-06-30 Stable oily suspension of microgranules

Country Status (2)

Country Link
AU (1) AU2003249904A1 (en)
WO (1) WO2004004682A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
WO2006026829A1 (en) * 2004-09-09 2006-03-16 Metelli Pty Ltd Stable paste composition of enteric coated acid labile active agent and use thereof
ITMO20050157A1 (en) 2005-06-22 2006-12-23 New Photocatalyst Solution Ltd SUSPENSIONS OF TITANIUM DIOXIDE AND METHOD OF OBTAINING THEM.
CN101966156B (en) * 2010-09-28 2012-08-22 石药集团欧意药业有限公司 Azithromycin for suspension and preparation method thereof
GB201306720D0 (en) * 2013-04-12 2013-05-29 Special Products Ltd Formulation
GB2535130B (en) * 2014-09-29 2020-09-02 Veriton Pharma Ltd A Suspension
US12472149B2 (en) 2015-07-17 2025-11-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
DE102018122533A1 (en) * 2018-09-14 2020-03-19 Institut Dr. Rilling Healthcare Gmbh Combustible and edible composition of medium-chain triglicerides and silica
CA3221045A1 (en) * 2021-06-01 2022-12-08 Andres Garcia Extended release drug delivery system for ocular drugs and methods of use
CN117881411A (en) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 Extended release drug delivery systems for ocular drugs and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
SE8605515D0 (en) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
EP0548238A1 (en) * 1990-09-13 1993-06-30 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
DE4200821A1 (en) * 1992-01-15 1993-07-22 Bayer Ag TASTE-MASKED PHARMACEUTICAL AGENTS
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same

Also Published As

Publication number Publication date
AU2003249904A8 (en) 2004-01-23
WO2004004682A3 (en) 2004-10-28
WO2004004682A2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2002363005A1 (en) Derivatives of uk-2a
AU2003202924A1 (en) Variation of neural-stimulation parameters
AU2003225444A1 (en) Oral suspension formulation
AU2003218758A1 (en) Derivatives of 1-phenyl-3-phenylpyrazole as herbicides
AU2003236991A1 (en) Representations of processes
AU2003255982A1 (en) Preparation of microcapsules
AU2003236009A1 (en) Vehicle capable of changing vehicle characteristics
AU2003277596A1 (en) Method of deuterization
AU2003249904A1 (en) Stable oily suspension of microgranules
AU2003238605A1 (en) Dynamic representations of processes
AU2003282755A1 (en) Methods of regulating body weight
AUPS096002A0 (en) Method of construction
AU2003267781A1 (en) Laser modification of complex objects
AU2003288237A1 (en) Artificial esterases
AU2003300609A1 (en) Suspension of particles having several phases
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2002950183A0 (en) Expression of hydrophobic proteins
AU2002952178A0 (en) Suspension assembly
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003230064A1 (en) Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
AU2003233068A1 (en) Core-assisted formation of microcapsules
AU2003288528A1 (en) Structure of handle-bars
AU2003255810A1 (en) Construction of lampshades
AU2003240450A1 (en) Manufacture of ketopantolactone
AU2003272036A1 (en) Specific markers of lipid peroxidation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase